Evaluation of an Extended-duration Chemoprophylaxis Regimen for Venous Thromboembolism after Microsurgical Breast Reconstruction

Autor: Eric M. Pittelkow, MD, Will C. DeBrock, MD, Brian Mailey, MD, Tarah J. Ballinger, MD, Juan Socas, MD, Mary E. Lester, MD, Aladdin H. Hassanein, MD, MMSc

Publikováno v: Plastic and Reconstructive Surgery, Global Open, Vol 9, Iss 8, p e3741 (2021)

Background:. Patients undergoing free flap breast reconstruction are at a high risk for venous thromboembolism based upon Caprini scores. Guidelines for venous thromboembolism prophylaxis recommend high-risk groups receive extended chemoprophylaxis f

Externí odkaz: https://doaj.org/article/7af148e78c234b04a38f9baf544bb6d6

Developmental Alcohol Exposure Impairs Activity-Dependent S-Nitrosylation of NDEL1 for Neuronal Maturation.

Autor: Saito A; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.; Department of Biological Psychiatry and Neuroscience, Dokkyo Medical University School of Medicine, Shimotsuga-gun, Tochigi 321-0293, Japan., Taniguchi Y; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA., Kim SH; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA., Selvakumar B; Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA., Perez G; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA., Ballinger MD; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA., Zhu X; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA., Sabra J; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA., Jallow M; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA., Yan P; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA., Ito K; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA., Rajendran S; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA., Hirotsune S; Department of Genetic Disease Research, Osaka City University Graduate School of Medicine, Abeno, Osaka 545-8585, Japan., Wynshaw-Boris A; Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, OH 44106, USA., Snyder SH; Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA., Sawa A; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.; Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA., Kamiya A; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

Publikováno v: Cerebral cortex (New York, N.Y. : 1991) [Cereb Cortex] 2017 Aug 01; Vol. 27 (8), pp. 3918-3929.

Early postnatal GABAA receptor modulation reverses deficits in neuronal maturation in a conditional neurodevelopmental mouse model of DISC1.

Autor: Saito A; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Biological Psychiatry and Neuroscience, Dokkyo Medical University School of Medicine, Tochigi, Japan., Taniguchi Y; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Rannals MD; Basic Sciences Division, Lieber Institute for Brain Development, Baltimore, MD, USA., Merfeld EB; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Ballinger MD; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Koga M; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Ohtani Y; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd, Kanagawa, Japan., Gurley DA; Neuroscience iMED, AstraZeneca, Cambridge, MA, USA., Sedlak TW; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Cross A; Neuroscience iMED, AstraZeneca, Cambridge, MA, USA., Moss SJ; Department of Neuroscience, Tufts University School of Medicine, Boston, MA, USA.; Department of Neuroscience, Physiology and Pharmacology, University College London, London, UK., Brandon NJ; Neuroscience iMED, AstraZeneca, Cambridge, MA, USA., Maher BJ; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Basic Sciences Division, Lieber Institute for Brain Development, Baltimore, MD, USA., Kamiya A; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Publikováno v: Molecular psychiatry [Mol Psychiatry] 2016 Oct; Vol. 21 (10), pp. 1449-59. Date of Electronic Publication: 2016 Jan 05.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Cannabidiol versus placebo as adjunctive treatment in early psychosis: study protocol for randomized controlled trial.

Autor: Dixon, T.¹ (AUTHOR), Cadenhead, K. S.¹ (AUTHOR) kcadenhead@health.ucsd.edu

Publikováno v: Trials. 11/30/2023, Vol. 24 Issue 1, p1-14. 14p.